2006
DOI: 10.1111/j.1464-5491.2006.01838.x
|View full text |Cite
|
Sign up to set email alerts
|

Mortality in people with Type 2 diabetes in the UK

Abstract: Aims  Under‐reporting of diabetes on death certificates contributes to the unreliable estimates of mortality as a result of diabetes. The influence of obesity on mortality in Type 2 diabetes is not well documented. We aimed to study mortality from diabetes and the influence of obesity on mortality in Type 2 diabetes in a large cohort selected from the General Practice Research Database (GPRD). Methods  A cohort of 44 230 patients aged 35–89 years in 1992 with Type 2 diabetes was identified. A comparison group … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

21
180
3
2

Year Published

2006
2006
2019
2019

Publication Types

Select...
5
4

Relationship

1
8

Authors

Journals

citations
Cited by 182 publications
(206 citation statements)
references
References 25 publications
21
180
3
2
Order By: Relevance
“…Overweight and obesity are associated with increased risks of cardiovascular morbidity and mortality in the general population [8][9][10][11][12][24][25][26][27], but only a few previous studies of type 2 diabetic patients have addressed the topic, and with somewhat conflicting results [13][14][15][16][28][29][30][31]. Our large observational study clearly shows an increased risk of fatal/non-fatal CHD (15%), stroke (11%), CVD (13%) and total mortality (27%) with a 5 unit increase in BMI at baseline after adjustment for age, sex, diabetes duration, type of hypoglycaemic treatment and smoking (model 1), and the risks were attenuated, but remained significant (except for stroke), when also adjusted for additional cardiovascular risk factors (e.g.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Overweight and obesity are associated with increased risks of cardiovascular morbidity and mortality in the general population [8][9][10][11][12][24][25][26][27], but only a few previous studies of type 2 diabetic patients have addressed the topic, and with somewhat conflicting results [13][14][15][16][28][29][30][31]. Our large observational study clearly shows an increased risk of fatal/non-fatal CHD (15%), stroke (11%), CVD (13%) and total mortality (27%) with a 5 unit increase in BMI at baseline after adjustment for age, sex, diabetes duration, type of hypoglycaemic treatment and smoking (model 1), and the risks were attenuated, but remained significant (except for stroke), when also adjusted for additional cardiovascular risk factors (e.g.…”
Section: Discussionmentioning
confidence: 99%
“…The results of our study, with obesity increasing the risk of total mortality by 71% (model 1), are supported by an observational study from Italy that followed 3,398 type 2 diabetic patients for 10 years, showing that obesity increased the risk of overall mortality by 74% in younger patients (<65 years old) (adjustment as in model 1), whereas excess weight predicted better survival in older patients [16]. An increased risk for total mortality with obesity was seen in the large UK General Practice Research Database (GPRD) study on type 2 diabetic patients (N=44,230, age 35-89 years, followed from 1992 to 1998), showing 13% and 43% increases in risk for BMI 30-34 kg/m 2 and 35-54 kg/m 2 compared with 20-24 kg/m 2 , respectively (adjustment as in model 1) [28]. An older, smaller WHO study found no association between BMI and total mortality [13].…”
Section: Discussionmentioning
confidence: 99%
“…Diabetes has been found to increase significantly mortality due to coronary heart disease and stroke in normal population (Laakso et al 1995;Tuomilehto et al 1996;Mulnier et al 2006;Raymond et al 1995;Whiteley et al 2005). Among the elderly Finnish population, survival of non-diabetics is better compared to diabetics in both genders.…”
Section: Discussionmentioning
confidence: 99%
“…Patients with type 2 diabetes were identified using an algorithm based on age at diagnosis and type of treatment. Full details of the cohort selection have been published elsewhere [22][23][24]. For each patient with type 2 diabetes five comparison subjects of the same age and sex and with no record of or treatment for diabetes at any time before 1992 or during the follow-up period were selected at random from the database.…”
Section: Methodsmentioning
confidence: 99%